Morgan Stanley’s DiaMedica Therapeutics DMAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $938K | Buy |
240,476
+136,893
| +132% | +$534K | ﹤0.01% | 5127 |
|
|
2025
Q1 | $393K | Buy |
103,583
+16,154
| +18% | +$61.2K | ﹤0.01% | 5436 |
|
|
2024
Q4 | $475K | Sell |
87,429
-22,587
| -21% | -$123K | ﹤0.01% | 5433 |
|
|
2024
Q3 | $461K | Buy |
110,016
+23,816
| +28% | +$99.8K | ﹤0.01% | 5440 |
|
|
2024
Q2 | $254K | Sell |
86,200
-5,373
| -6% | -$15.9K | ﹤0.01% | 5575 |
|
|
2024
Q1 | $254K | Sell |
91,573
-150,417
| -62% | -$417K | ﹤0.01% | 5639 |
|
|
2023
Q4 | $687K | Buy |
241,990
+148,190
| +158% | +$421K | ﹤0.01% | 5480 |
|
|
2023
Q3 | $242K | Buy |
93,800
+36,700
| +64% | +$94.7K | ﹤0.01% | 5499 |
|
|
2023
Q2 | $247K | Sell |
57,100
-88
| -0.2% | -$380 | ﹤0.01% | 5550 |
|
|
2023
Q1 | $87.5K | Buy |
57,188
+1,987
| +4% | +$3.04K | ﹤0.01% | 6063 |
|
|
2022
Q4 | $87.2K | Buy |
55,201
+2,194
| +4% | +$3.47K | ﹤0.01% | 6043 |
|
|
2022
Q3 | $66K | Buy |
53,007
+5,207
| +11% | +$6.48K | ﹤0.01% | 6274 |
|
|
2022
Q2 | $96K | Buy |
47,800
+14,377
| +43% | +$28.9K | ﹤0.01% | 6296 |
|
|
2022
Q1 | $84K | Buy |
33,423
+9,523
| +40% | +$23.9K | ﹤0.01% | 6427 |
|
|
2021
Q4 | $89K | Buy |
23,900
+12,500
| +110% | +$46.5K | ﹤0.01% | 6504 |
|
|
2021
Q3 | $46K | Sell |
11,400
-12,227
| -52% | -$49.3K | ﹤0.01% | 6760 |
|
|
2021
Q2 | $105K | Buy |
23,627
+4,202
| +22% | +$18.7K | ﹤0.01% | 6338 |
|
|
2021
Q1 | $178K | Sell |
19,425
-1,235
| -6% | -$11.3K | ﹤0.01% | 5720 |
|
|
2020
Q4 | $210K | Buy |
20,660
+11,560
| +127% | +$118K | ﹤0.01% | 5563 |
|
|
2020
Q3 | $38K | Buy |
9,100
+3,300
| +57% | +$13.8K | ﹤0.01% | 5819 |
|
|
2020
Q2 | $41K | Buy |
+5,800
| New | +$41K | ﹤0.01% | 5741 |
|